The thrombogenicity of the dienogest/estradiolvalerate-containing oral contraceptive (Qlaira(R)).

Trial Profile

The thrombogenicity of the dienogest/estradiolvalerate-containing oral contraceptive (Qlaira(R)).

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Feb 2013

At a glance

  • Drugs Estradiol valerate/dienogest (Primary) ; Ethinylestradiol/levonorgestrel
  • Indications Pregnancy
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Feb 2013 Status changed from recruiting to completed.
    • 18 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top